Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
26,475,256
-
Number of holders
-
59
-
Total 13F shares, excl. options
-
7,070,182
-
Shares change
-
+2,791,039
-
Total reported value, excl. options
-
$139,896,335
-
Value change
-
+$55,735,706
-
Number of buys
-
34
-
Number of sells
-
-22
-
Price
-
$19.82
Significant Holders of AVITA Medical, Inc. - Common Stock (RCEL) as of Q1 2021
74 filings reported holding RCEL - AVITA Medical, Inc. - Common Stock as of Q1 2021.
AVITA Medical, Inc. - Common Stock (RCEL) has 59 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 7,070,182 shares
of 26,475,256 outstanding shares and own 26.7% of the company stock.
Largest 10 shareholders include Redmile Group, LLC (1,668,327 shares), VANGUARD GROUP INC (1,063,971 shares), Farallon Capital Management, L.L.C. (800,000 shares), STATE STREET CORP (444,749 shares), Blackcrane Capital, LLC (418,194 shares), PURA VIDA INVESTMENTS, LLC (383,589 shares), RTW INVESTMENTS, LP (280,000 shares), BlackRock Inc. (277,127 shares), MILLENNIUM MANAGEMENT LLC (268,581 shares), and GEODE CAPITAL MANAGEMENT, LLC (196,572 shares).
This table shows the top 59 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.